Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate
Reports of Radiotherapy and Oncology · 2015
DOI: 10.17795/rro-3093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reports of Radiotherapy and Oncology, 2015. Verfasst von Kambiz Novin und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Novin, K., Moghadam, S., Mortazavi, N., Kamal, F. H., Ahmadi, H. K., & Ameri, A. (2015). Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate. Reports of Radiotherapy and Oncology. https://doi.org/10.17795/rro-3093
Vancouver
Novin K, Moghadam S, Mortazavi N, Kamal FH, Ahmadi HK, Ameri A. Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate. Reports of Radiotherapy and Oncology. 2015. doi:10.17795/rro-3093
BibTeX
@article{Novin2015,
author = {Novin, Kambiz and Moghadam, Shiva and Mortazavi, Nafiseh and Kamal, Farnaz Hosseini and Ahmadi, Helaleh Khoshbakht and Ameri, Ahamd},
title = {Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate},
journal = {Reports of Radiotherapy and Oncology},
year = {2015},
doi = {10.17795/rro-3093}
}
EUVIMED